Clinical Trial Update: New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a new combination regimen of L-asparaginase, dexamethasone, ifosfamide, cisplatin, and etoposide for extranodal NK/T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• CISPLATIN (cisplatin)
• DEXAMETHASONE (Dexamethasone)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• L-asparaginase (L-asparaginase)

Snippet

Sponsor: Fudan University | Conditions: Lymphoma | Phase 2 | Status: UNKNOWN